BIOEXTRAX AB (85X0) - Net Assets
Based on the latest financial reports, BIOEXTRAX AB (85X0) has net assets worth €16.89 Million EUR (≈ $19.74 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€19.00 Million ≈ $22.21 Million USD) and total liabilities (€2.11 Million ≈ $2.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see market value of BIOEXTRAX AB.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €16.89 Million |
| % of Total Assets | 88.87% |
| Annual Growth Rate | 29.69% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 145.82 |
BIOEXTRAX AB - Net Assets Trend (2021–2025)
This chart illustrates how BIOEXTRAX AB's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for BIOEXTRAX AB (2021–2025)
The table below shows the annual net assets of BIOEXTRAX AB from 2021 to 2025. See debt-free asset ratio of BIOEXTRAX AB to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €21.21 Million ≈ $24.80 Million |
-18.59% |
| 2024-12-31 | €26.06 Million ≈ $30.47 Million |
+26.89% |
| 2023-12-31 | €20.54 Million ≈ $24.01 Million |
-35.35% |
| 2022-12-31 | €31.77 Million ≈ $37.14 Million |
+323.62% |
| 2021-12-31 | €7.50 Million ≈ $8.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BIOEXTRAX AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1588400000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €6.68 Million | 31.49% |
| Other Components | €14.54 Million | 68.51% |
| Total Equity | €21.21 Million | 100.00% |
BIOEXTRAX AB Competitors by Market Cap
The table below lists competitors of BIOEXTRAX AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Spineguard
PA:ALSGD
|
$10.43 Million |
|
mVISE AG
XETRA:C1V
|
$10.43 Million |
|
Centrex Ltd
AU:CXM
|
$10.44 Million |
|
Txcom SA
PA:ALTXC
|
$10.44 Million |
|
Yelooo Integra Datanet Tbk PT
JK:YELO
|
$10.42 Million |
|
Tian An Australia Ltd
AU:TIA
|
$10.42 Million |
|
Landmark Property Development Company Limited
NSE:LPDC
|
$10.42 Million |
|
Vessel Co. Ltd
KQ:177350
|
$10.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIOEXTRAX AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 26,059,000 to 21,215,000, a change of -4,844,000 (-18.6%).
- Net loss of 17,705,000 reduced equity.
- New share issuances of 15,490,000 increased equity.
- Other factors decreased equity by 2,629,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-17.70 Million | -83.46% |
| Share Issuances | €15.49 Million | +73.01% |
| Other Changes | €-2.63 Million | -12.39% |
| Total Change | €- | -18.59% |
Book Value vs Market Value Analysis
This analysis compares BIOEXTRAX AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.38x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.45 | €0.20 | x |
| 2022-12-31 | €1.23 | €0.20 | x |
| 2023-12-31 | €0.69 | €0.20 | x |
| 2024-12-31 | €0.66 | €0.20 | x |
| 2025-12-31 | €0.53 | €0.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BIOEXTRAX AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -83.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2338.84%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.17x
- Recent ROE (-83.46%) is above the historical average (-90.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -140.45% | -3815.94% | 0.02x | 1.69x | €-11.28 Million |
| 2022 | -58.76% | -4725.82% | 0.01x | 1.19x | €-21.84 Million |
| 2023 | -104.73% | -1046.06% | 0.09x | 1.10x | €-23.56 Million |
| 2024 | -66.53% | -3366.60% | 0.02x | 1.11x | €-19.94 Million |
| 2025 | -83.46% | -2338.84% | 0.03x | 1.17x | €-19.83 Million |
Industry Comparison
This section compares BIOEXTRAX AB's net assets metrics with peer companies in the Waste Management industry.
Industry Context
- Industry: Waste Management
- Average net assets among peers: $2,984,141,115
- Average return on equity (ROE) among peers: -51.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIOEXTRAX AB (85X0) | €16.89 Million | -140.45% | 0.13x | $10.42 Million |
| BACTECH ENVIRONMENT.CORP. (0BT1) | $-1.42 Million | 0.00% | 0.00x | $6.00 Million |
| SCANDIN.ENVIRO SYSTEMS AB (1HR) | $225.79 Million | -162.37% | 0.24x | $8.11 Million |
| GEM CO. LTD SP.GDR/10 A (3730) | $25.35 Billion | 6.23% | 1.92x | $4.59 Billion |
| AGILYX ASA NK -02 (5NQ) | $7.06 Million | -311.75% | 2.48x | $200.74 Million |
| GEOTRANS S.A. ZY -10 (5Z4) | $26.66 Million | -6.40% | 0.06x | $5.10 Million |
| ECOUP OYJ EO 1 (62H) | $23.39 Million | 4.43% | 0.60x | $10.20 Million |
| ELL ENVIRON.HLDGS HD-0001 (6EL) | $252.81 Million | -3.45% | 1.04x | $11.07 Million |
| NEOMETALS LTD SP.ADS/10 (9R91) | $126.60 Million | 3.44% | 0.04x | $3.15 Million |
| Befesa SA (BFSA) | $845.74 Million | 6.01% | 1.34x | $1.45 Billion |
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; … Read more